All Stories

  1. Immunomodulation Followed by Antigen-Specific Treg Infusion Controls Islet Autoimmunity
  2. Small‐molecule modulators of the OX40–OX40 ligand co‐stimulatory protein–protein interaction
  3. T Regulatory Cell Adoptive Therapy for Tolerance Induction in Autoimmunity and Transplantation
  4. The IL-2/IL-2R system: from basic science to therapeutic applications to enhance immune regulation
  5. Expansion of a restricted residual host Treg‐cell repertoire is dependent on IL‐2 following experimental autologous hematopoietic stem transplantation
  6. IL-2 Family of Cytokines in T Regulatory Cell Development and Homeostasis
  7. The Role of IL-2 in the Development and Peripheral Homeostasis of Naturally Occurring CD4 + CD25 + Foxp3 + Regulatory T Cells
  8. Tolerance, not immunity, crucially depends on IL-2
  9. Alterations in protein kinase C isoenzyme expression and autophosphorylation during the progression of pressure overload-induced left ventricular hypertrophy
  10. Differential activation of mitogen-activated protein kinase cascades by protein kinase C (PKC) delta and epsilon
  11. PYK2 Expression and Phosphorylation in Neonatal and Adult Cardiomyocytes
  12. ENHANCED ALLOGRAFT SURVIVAL VIA SIMULTANEOUS BLOCKADE OF TRANSFERRIN RECEPTOR AND INTERLEUKIN-2 RECEPTOR1
  13. Differential effects of transferrin receptor blockade on the cellular mechanisms involved in graft rejection
  14. Emerging therapeutic targets in immunosuppression: the transferrin receptor
  15. SYNERGISTIC EFFECTS OF ANTI-TRANSFERRIN RECEPTOR AND ANTI-IL-2 RECEPTOR MONOCLONAL ANTIBODIES ON T CELL RESPONSES TO ALLOANTIGEN
  16. T-CELL ALTERATIONS IN CARDIAC ALLOGRAFT RECIPIENTS AFTER B7 (CD80 AND CD86) BLOCKADE1
  17. ALTERATIONS IN T CELL EFFECTOR MECHANISMS FOLLOWING TRANSFERRIN RECEPTOR BLOCKADE
  18. ALTERATIONS IN T CELL EFFECTOR MECHANISMS FOLLOWING TRANSFERRIN RECEPTOR BLOCKADE
  19. ANTI-TRANSFERRIN RECEPTOR MONOCLONAL ANTIBODY